Harrow Health is trading at $32.00, up 6.70%, with healthcare’s pre-market gain and positive sector earnings reports potentially supporting the move.
- No fresh company-specific announcement was identified; the broader market is mixed to weak and does not clearly explain the rise.
- Shares climbed from $28.24 on October 21 to $29.99 at the October 29 close; pre-market volume was not provided.
- Harrow’s next quarterly results are scheduled for November 9, 2026.